Accolade (ACCD) Set to Announce Quarterly Earnings on Thursday

Accolade (NASDAQ:ACCDGet Rating) will release its earnings data after the market closes on Thursday, April 28th. Analysts expect Accolade to post earnings of ($0.45) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

ACCD opened at $12.91 on Thursday. Accolade has a fifty-two week low of $12.43 and a fifty-two week high of $55.47. The business has a 50-day moving average of $16.45 and a 200-day moving average of $24.42. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.21 and a quick ratio of 2.21. The company has a market capitalization of $864.43 million, a PE ratio of -7.46 and a beta of 2.02.

A number of research firms have recently weighed in on ACCD. Guggenheim assumed coverage on Accolade in a research note on Wednesday, April 6th. They set a “neutral” rating for the company. BTIG Research cut their price objective on Accolade from $60.00 to $35.00 in a research note on Tuesday, January 11th. Wells Fargo & Company assumed coverage on Accolade in a research note on Monday, April 11th. They issued an “underweight” rating and a $9.00 price objective on the stock. Morgan Stanley cut their price objective on Accolade from $31.00 to $30.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 11th. Finally, Piper Sandler cut their price objective on Accolade from $35.00 to $22.00 in a research note on Wednesday, April 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $36.92.

A number of hedge funds have recently modified their holdings of ACCD. Ensign Peak Advisors Inc bought a new position in Accolade in the fourth quarter worth $31,000. Royal Bank of Canada lifted its holdings in shares of Accolade by 45.5% during the third quarter. Royal Bank of Canada now owns 6,484 shares of the company’s stock valued at $273,000 after acquiring an additional 2,029 shares during the period. Citigroup Inc. lifted its holdings in shares of Accolade by 53.5% during the fourth quarter. Citigroup Inc. now owns 13,799 shares of the company’s stock valued at $364,000 after acquiring an additional 4,809 shares during the period. Parametric Portfolio Associates LLC lifted its holdings in shares of Accolade by 263.0% during the fourth quarter. Parametric Portfolio Associates LLC now owns 25,136 shares of the company’s stock valued at $663,000 after acquiring an additional 18,211 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of Accolade by 3.6% during the fourth quarter. The Manufacturers Life Insurance Company now owns 26,120 shares of the company’s stock valued at $689,000 after acquiring an additional 898 shares during the period. 72.18% of the stock is owned by hedge funds and other institutional investors.

About Accolade (Get Rating)

Accolade, Inc develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists.

See Also

Earnings History for Accolade (NASDAQ:ACCD)

Receive News & Ratings for Accolade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accolade and related companies with MarketBeat.com's FREE daily email newsletter.